Global Metabolomics Market 2014-2018

Price :
Published : Jul-2014
No. of Pages : 86

Report Description

Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics.

TechNavio’s analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.

Covered in this Report

The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.

TechNavio’s report, the Global Metabolomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Human Metabolome Technologies Inc.
  • Metabolon Inc.

Other Prominent Vendors

  • Acadia Pharmaceuticals
  • Accelrys
  • BG Medicine
  • Biocrates Life Sciences
  • Chenomx
  • Life Technologies
  • Metabolomic Technologies
  • Nanosyn
  • PerkinElmer
  • Waters

Key Market Driver

  • Increase in Prevalence of Cancer and Diabetes
  • For a full, detailed list, view our report

Key Market Challenge

  • Quality Control Standards of Metabolic Profiling Data
  • For a full, detailed list, view our report

Key Market Trend

  • Emergence of Standards to Analyze Metabolomics Data
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation
09.1 Metabolomics Market in the Americas
09.1.1 Market Size and Forecast
09.2 Metabolomics Market in the EMEA
09.2.1 Market Size and Forecast
09.3 Metabolomics Market in the APAC
09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors

18. Key Vendor Analysis
18.1 Agilent Technologies
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Sales by Geography
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.1.9 Strengths
18.1.10 Weaknesses
18.1.11 Opportunities
18.1.12 Threats
18.2 Bio-Rad Laboratories
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2012
18.2.4 Business Segmentation by Revenue 2012 and 2011
18.2.5 Geographical Segmentation by Revenue 2012
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.2.9 Strengths
18.2.10 Weakness
18.2.11 Opportunities
18.2.12 Threats
18.3 Bruker
18.3.1 Key Facts
18.3.2 Business Overview/ Description
18.3.3 Business Segmentation
18.3.4 Business Strategy
18.3.5 Revenue Segmentation by Business /Products
18.3.6 Sales by Geographical Segmentation
18.3.7 Key Information
18.3.8 SWOT Analysis
18.3.9 Strengths
18.3.10 Weaknesses
18.3.11 Opportunities
18.3.12 Threats
18.4 Human Metabolome Technologies
18.4.1 Key Facts
18.4.2 Business Overview/ Description
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Revenue Segmentation by Business
18.4.6 Sales by Geographical Segmentation
18.4.7 Key Information
18.4.8 SWOT Analysis
18.4.9 Strengths
18.4.10 Weaknesses
18.4.11 Opportunities
18.4.12 Threats
18.5 Metabolon Inc.
18.5.1 Key Facts
18.5.2 Business Overview/Description
18.5.3 Business Segmentation
18.5.4 Business Strategy
18.5.5 Key Information
18.5.6 SWOT Analysis
18.5.7 02.2.1 Strengths
18.5.8 02.2.2 Weaknesses
18.5.9 02.2.3 Opportunities
18.5.10 02.2.4 Threats

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Metabolomics Market 2013-2018 (US$ million)
Exhibit 3: Global Metabolomics Market Segmentation by Technology
Exhibit 4: Global Metabolomics Market Segmentation by Application
Exhibit 5: Global Metabolomics Market by Geographical Segmentation 2013
Exhibit 6: Global Metabolomics market by Geographical Segmentation in 2018
Exhibit 7: Metabolomics Market in the Americas 2013-2018 (US$ million)
Exhibit 8: Metabolomics market in the EMEA region 2013-2018 (US$ million)
Exhibit 9: Metabolomics Market in the APAC region 2013-2018 (US$ million)
Exhibit 10: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 11: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 12: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 13: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 14: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 15: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 16: Business segments for Human Metabolome Technologies
Exhibit 17: Revenue Segmentation of Global Metabolomics Market 2014-2018 for 2013
Exhibit 18: Revenue Segmentation of Global Metabolomics Market 2014-2018 by Geography for 2013
Exhibit 19: Metabolon Inc. Business Segmentation

Press Release

TechNavio Announces the Publication of its Research Report - Global Metabolomics Market 2014-2018

TechNavio recognizes the following companies as the key players in the Global Metabolomics Market : Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., Metabolon Inc. , Acadia Pharmaceuticals , Accelrys, BG Medicine, Biocrates Life Sciences, Chenomx, Life Technologies, Metabolomic Technologies , Nanosyn, PerkinElmer, Waters

Commenting on the report, an analyst from TechNavio’s team said: “The increasing amount of metabolomics data produced each year requires a standard and reproducible way to link data for enhanced flow of information. Standards such as MSI and COSMOS have been introduced to standardize metabolomics data. COSMOS is a project for metabolomics that generates large and diversified sets of analytical data. COSMOS captures and stores large volumes of data by having e-infrastructure metabolomics communities such as ELIXIR, EU-OPENSCREEN and BBMRI that develop and maintain open-source exchange formats for raw and processed data”

According to the report, the Global Metabolomics market is driven by several factors. An increase in the prevalence of cancer and diabetes worldwide is one of the major drivers of this market. Metabolite profiling has become an important diagnostic procedure for the detection and diagnosis of cancer, diabetes, and other chronic diseases.

Further, the report states that one of the major challenges in the market is the quality control standards for metabolic profiling data. The vast diversity of metabolites makes it impossible to analyze the biomolecules on a single analytical platform. Therefore, it is difficult to accumulate and store large amount of metabolomics data.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Filed in: Biotechnology
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Cell Culture Protein Surface Coating Market 2015-2019

Cell culture protein surface coating is a procedure in which the cell culture surfaces are coated with proteins or extracellular matrix components to enhance the adhesion and proliferation of the cells in vitro. The following are the different types of available proteins: human-derived proteins, animal-derived proteins, plant-derived proteins, and synthetic proteins. Proteins such as fibronectin, laminin, collagen, vitronectin, and osteopontin are used for cell culture protein surface coating. Protein surface coating helps in the growth of various types of cells such as endothelial, epithelial, fibroblasts, leukocytes, myoblasts and muscle cells, neurons, and CHO cell lines. Cell culture protein surface coating provides improved adhesion, proliferation, and rapid growth of cells during iso......
$2500

Global Digital PCR (dPCR) Market 2015-2019

Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The dPCR technology is an innovative PCR that allows amplification and directs quantification of nucleic acids such as DNA, RNA, cDNA, and methylated DNA with high precision. The dPCR technology is not dependent on the number of amplification cycles to quantify the initial sample amount and provides absolute quantification of nucleic acids. dPCR can analyze a small amount of sample and provide higher accuracy, precision, and efficiency than the conventional PCR technology. TechNavio's analysts forecast the Global dPCR market to grow at a CAGR of 26.45 percent over the period 2014-2019. Covered in this Report The rep......
$2500

Global Cancer Biomarkers Market 2015-2019

Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. Cancer Biomarkers are proteins or metabolites indicative of tumor state and progression characteristics. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. The best example of a cancer biomarker is that of prostate specific antigen. PSA is measured in the blood to screen for and monitor treatment for prostate cancer. PSA, as a biomarker helps the......
$2500

Global Bio-detection Market 2014-2018

Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, which signals the entry or the existence of a virus. The increasing attacks have brought a major concern to the public as well as governments. Attacks such as the 2001 Anthrax scare, the 2003 severe acute respiratory syndrome (SARS), the 2004 Ricin letters, the 2009 H1N1, and the 2014 Ebola outbreaks have driven governments to increase their bio-surveillance budgets. TechNavio's analysts forecast the Global Bio-de......
$2500

Global qPCR and dPCR Market 2015-2019

qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic acids amplification and analysis. qPCR allows amplification and quantification of a targeted DNA molecule in real-time. While dPCR is an advanced PCR that allows direct quantification and amplification of nucleic acids including RNA, DNA, cDNA, methylated DNA. It does not rely on the number of amplification cycles to measure the initial sample amount and provides absolute quantification of nucleic acid. qPCR and dPCR need a small amount of sample and provide higher accuracy, sensitivity, and efficiency than conventional PCR. These technologies are widely used in various research and diagnostic applications such......
$3000

Global Gene Expression Market 2015-2019

Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers to study gene expression and its impact on cell function. Researchers use gene expression profiling and analysis for various applications in the areas of drug discovery and development, clinical diagnostics, and other research purposes. Advanced PCR, NGS, and DNA microarray technology allow profiling and analysis of thousands of genes in a very short period with great accuracy and reproducibility. TechNavio's analysts forecast the Global Gene Expression market to grow at a CAGR of 11.12 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the gro......
$3000

Global Prenatal and Newborn Genetic Testing Market 2015-2019

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders. TechNavio's analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global Prenatal and Ne......
$2500

Global Microarray market 2015-2019

Microarray technology is used for studying the expression of biological materials such as DNA, RNA, small portions of tissue, or protein by immobilizing them onto a solid support such as a glass slide or silicon thin-film. The microarray analyzes large amounts of biological material using HTS miniaturized, multiplexed, and parallel processing and detection methods for a limited time with high accuracy and efficiency. Microarrays are developed by robotic machines that arrange small amounts of hundreds of biomaterial on a single slide. There are various types of microarray, including chemical compound, cellular, DNA, protein, RNA, and tissue microarrays and LOC. The technology has a broad range of applications such as in the genomic and proteomic studies for drug discovery and development, c......
$2500

Global Transfection Technologies Market 2015-2019

Transfection technology is used for the introduction of nucleic acids into desired cells. The process enables the expression of desired proteins in efficient cells. A stable transfection enables the integration of this foreign nucleic acid into the cellular DNA resulting in the expression of the desired proteins in cell lines. The process, which can be accomplished by various physical, chemical, or viral methods, can be used for potential applications such as gene therapy, protein production, and drug discovery. TechNavio's analysts forecast the Global Transfection Technologies market to grow at a CAGR of 8.71 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects and future prospects of the Global Transfection Te......
$2500

Global Regenerative Medicine Market 2015-2019

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, cell therapy, and gene therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues. Whereas cell therapy helps in treating the functioning of the existing cells, gene therapy helps in the correction of defective genes of the body. TechNavio's analysts forecast the Global Regenerative Medicine market to grow at a CAGR of 20.16 percent over the period 2014-2019. Covere......
$2500